Mangalam Drugs and Organics Share Price

    74.3
    -0.16 (-0.21%)
    MANGALAM • 29 Aug, 2025 | 03:29 PM
    Buy

    1Y Annualised Return

    -40.46%

    3Y Annualised Return

    -18.68%

    5Y Annualised Return

    -11.78%

    10Y Annualised Return

    -0.60%

    The current prices are delayed, login or Open Demat Account for live prices.

    Mangalam Drugs and Organics Stock Performance

    1W Return-9.17
    1Y Return-43.13
    Today's Low73.68
    Prev. Close74.46
    Mkt Cap (Cr.)117.60
    1M Return-16.96
    3Y Return-49.09
    52-Week High140.5
    Open74.31
    PE Ratio0.00
    6M Return-19.17
    Today's High76.49
    52-Week Low70.1
    Face Value10

    Mangalam Drugs and Organics Company background

    Founded in: 1972
    Managing director: Govardhan M Dhoot
    Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd. Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an inhouse Research and Development (RD) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company. In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine. In the year 20032004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 200405, the capacity is being further enhanced to 960 MTPA. During the year 200506, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum.During the year 200708, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline Allied Products from 250 tons to 350 tons.During the year 200910, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHOGeneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.During the year 201718, Unit 2 of the Company received WHO Approvals for manufacturing of the Active Pharmaceutical ingredients comprising of Lumefantrine (APIMF100) Tenofovir Disoproxil Fumarate (APIMF204) Artemether (APIMF138) Emtricitabine (WHO API314) Efavirenz (WHO API 318).

    Mangalam Drugs and Organics Financial Highlights


    Mangalam Drugs and Organics reported a Q1 FY 2025-26 revenue of ₹57.35 crore, down -13.6% YoY, with net profit decreased -174.1% to ₹-13.8 crore. For the full year FY2025–2026, revenue reached ₹318.73 crore and profit touched at ₹6.72 crore.

    As of 29 Aug, 2025, Mangalam Drugs and Organics share price is ₹74.3. The stock opened at ₹74.3 and had closed at ₹74.5 the previous day. During today’s trading session, Mangalam Drugs and Organics share price moved between ₹73.68 and ₹76.49, with an average price for the day of ₹75.09. Over the last 52 weeks, the stock has recorded a low of ₹70.10 and a high of ₹140.50. In terms of performance, Mangalam Drugs and Organics share price has declined by 24.3% over the past six months and has declined by 40.46% over the last year.
    Read More
    Mangalam Drugs and Organics SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years
    Total Investment of ₹65,00,000
    Would have become ₹53,40,867 (-17.83%)
    Daily SIP of 25,000 would have become 53,40,867 in 1 year with a gain of -11,59,132 (-17.83%)
    View details of Market Depth

    Mangalam Drugs and Organics Fundamental

    Market Cap (in crs)

    117.60

    Face Value

    10

    Turnover (in lacs)

    32.10

    Key Metrics

    Qtr Change %
    47.12% Fall from 52W High
    -6.8
    Dividend yield 1yr %
    0

    Mangalam Drugs and Organics Key Financials

    View more
    Loading chart...
    Loading chart...
    Loading chart...
    Loading chart...
    Mangalam Drugs and Organics Quarterly Revenue
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    57.35 Cr
    73.04 Cr
    88.71 Cr
    79.94 Cr
    76.54 Cr
    Mangalam Drugs and Organics Yearly Revenue
    Mar 2025Mar 2024Mar 2022Mar 2021
    318.73 Cr
    368.69 Cr
    533.48 Cr
    303.32 Cr
    Mangalam Drugs and Organics Quarterly Net Profit/Loss
    Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
    -13.8 Cr
    0.06 Cr
    1.29 Cr
    2.69 Cr
    2.68 Cr
    Mangalam Drugs and Organics Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2022Mar 2021
    6.72 Cr
    -9.07 Cr
    12.31 Cr
    2.65 Cr

    Mangalam Drugs and Organics Result Highlights

    • Mangalam Drugs and Organics Ltd reported a 43.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 25.1%.

    • Its expenses for the quarter were down by 28.5% QoQ and 7.4% YoY.

    • The net profit decreased 490.9% QoQ and decreased 614.9% YoY.

    • The earnings per share (EPS) of Mangalam Drugs and Organics Ltd declined at 8.7 during Q1 FY 2025-26.

      Read more

    Data Source: BSE, Company announcements

    The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

    Mangalam Drugs and Organics Shareholding Pattern

    Promoter
    50.3%
    Foreign Institutions
    0.5%
    Public
    49.2%
    Promoter
    50.3%
    Foreign Institutions
    0.5%
    Public
    49.2%
    Promoter
    50.3%
    Foreign Institutions
    0.1%
    Public
    49.6%
    Promoter
    50.3%
    Foreign Institutions
    0.1%
    Public
    49.6%
    Promoter
    50.3%
    Foreign Institutions
    0.2%
    Public
    49.5%
    Promoter
    50.3%
    Foreign Institutions
    0.3%
    Public
    49.4%

    Mangalam Drugs and Organics Technical Analysis

    Moving Averages Analysis
    74.3
    Current Price
    Bullish Moving Averages
    0
    Bearish Moving Averages
    16
    5Day EMA
    76.90
    10Day EMA
    78.50
    12Day EMA
    79.00
    20Day EMA
    80.60
    26Day EMA
    81.30
    50Day EMA
    82.50
    100Day EMA
    84.70
    200Day EMA
    90.50
    5Day SMA
    78.00
    10Day SMA
    79.60
    20Day SMA
    81.10
    30Day SMA
    83.80
    50Day SMA
    83.80
    100Day SMA
    81.60
    150Day SMA
    85.70
    200Day SMA
    92.50
    Delivery & Volume
    Loading chart...

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    29128 Rs
    46275 Rs
    Week Rs
    28685 Rs
    51112 Rs
    Month Rs
    22966 Rs
    46073 Rs
    74.82
    Pivot
    Resistance
    First Resistance
    75.97
    Second Resistance
    77.63
    Third Resistance
    78.78
    Support
    First Support
    73.16
    Second support
    72.01
    Third Support
    70.35
    Relative Strength Index
    35.77
    Money Flow Index
    26.79
    MACD
    -2.31
    MACD Signal
    -1.72
    Average True Range
    4.50
    Average Directional Index
    19.49
    Rate of Change (21)
    -16.96
    Rate of Change (125)
    -27.96

    Mangalam Drugs and Organics Latest News

    28 AUG 2025 | Thursday

    Mangalam Drugs & Organics Ltd - 532637 - Board Meeting Intimation for Board Meeting Intimation To Be Held On 5Th September, 2025 Inter Alia To Approve Appointment Of Secretarial Auditor For The Period Of 5 Years And Re-Appointment Of Director Who Is Retiring By Rotation.

    22 AUG 2025 | Friday

    Mangalam Drugs & Organics Ltd - 532637 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

    14 AUG 2025 | Thursday

    Mangalam Drugs & Organics Ltd - 532637 - Intimation Of Voting Results And Scrutinizer''s Report Of Tribunal Convened Equity Shareholders Meeting Held On 12Th August, 2025 At 12.30 P.M.

    View More

    Mangalam Drugs and Organics Share Price FAQs

    Mangalam Drugs and Organics share price is ₹74.3 in NSE and ₹74.18 in BSE as on 29/8/2025.

    Mangalam Drugs and Organics share price in the past 1-year return was -43.12. The Mangalam Drugs and Organics share hit a 1-year low of Rs. 70.1 and a 1-year high of Rs. 140.5.

    The market cap of Mangalam Drugs and Organics is Rs. 117.6 Cr. as of 29/8/2025.

    The PE ratios of Mangalam Drugs and Organics is 0 as of 29/8/2025.

    The PB ratios of Mangalam Drugs and Organics is 0.78 as of 29/8/2025

    You can easily buy Mangalam Drugs and Organics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Mangalam Drugs and Organics share price is ₹140.5 and ₹70.1 as of 29/8/2025.

    The earnings per share (EPS) of Mangalam Drugs and Organics declined at 8.7 during Q1 FY 2025-26.

    Please be aware that Mangalam Drugs and Organics stock prices are subject to continuous fluctuations due to various factors.

    Open Demat Account
    +91 -

    Popular Stocks
    56.43
    +0.11 (+0.20%)
    118.11
    -0.47 (-0.40%)
    669.00
    -6.45 (-0.95%)
    2,244.70
    -30.50 (-1.34%)
    140.50
    -0.53 (-0.38%)
    302.60
    -6.05 (-1.96%)
    154.48
    +0.85 (+0.55%)
    313.95
    -1.55 (-0.49%)
    369.40
    +5.55 (+1.53%)
    374.15
    +3.05 (+0.82%)
    Top Gainers
    409.75
    +8.85 (+2.21%)
    369.40
    +5.55 (+1.53%)
    580.25
    +8.60 (+1.50%)
    5,298.00
    +62.50 (+1.19%)
    2,518.60
    +29.60 (+1.19%)
    Top Losers
    3,199.50
    -95.80 (-2.91%)
    1,357.20
    -28.70 (-2.07%)
    1,469.60
    -30.50 (-2.03%)
    7,610.00
    -118.00 (-1.53%)
    2,244.70
    -30.50 (-1.34%)
    Open Demat Account
    +91 -